#United States #New York #Class Action #The Gross Law Firm #Cerevel Therapeutics

Important Notice for Shareholders of Cerevel Therapeutics Holdings, Inc.

Shareholders of Cerevel Therapeutics Holdings, Inc. (NYSE: ABBV) who realized losses on their investment are urged to reach out to The Gross Law Firm regarding a pending class action lawsuit. This communication serves as a formal advisory for stakeholders who purchased shares during a specified class period. The implications of this class action and individual rights need to be understood thoroughly by affected shareholders.

Who Should Contact?

Individuals or entities that either sold or disposed of Cerevel’s publicly-traded common stock between October 11, 2023, and August 1, 2024, including those who held their shares as of January 8, 2024, and participated in the voting for Cerevel's merger with AbbVie, are encouraged to communicate with the law firm. Additionally, shareholders who sold their shares around the same time Bain Capital made a hefty purchase on October 16, 2023, might be affected by the legal proceedings.

What Are the Allegations?

The lawsuit centers on allegations that Cerevel's stock offering in October 2023 contained omissions and misleading statements concerning AbbVie's intentions. The accusation suggests that appropriate facts regarding a substantial acquisition offer were not disclosed, resulting in an artificially low stock price until the merger was publicly acknowledged. Bain Capital allegedly acquired shares at this deflated price while possessing crucial inside information about AbbVie's acquisition plan. Subsequently, on December 6, 2023, AbbVie announced its agreement to acquire Cerevel at a significantly higher price of $45 per share, resulting in an extraordinary profit for Bain Capital.

Furthermore, it has been alleged that Cerevel's proxy statement released on January 18, 2024, failed to clarify the nature and timeline of AbbVie's interest, thereby potentially misguiding investors.

Deadlines to Remember

The deadline for shareholders to register for this class action is June 3, 2025. It is vital for affected parties to act swiftly to ensure their participation in this significant legal action, as the opportunity may not be available indefinitely. Registration can easily be done via The Gross Law Firm's website, providing shareholders automatic updates regarding the case’s developments throughout its progression.

Why The Gross Law Firm?

Included in this notice is a discussion on The Gross Law Firm's dedication to protecting investors' rights who have suffered due to potential fraud or misleading company practices. They aim to recover losses incurred from misleading statements or crucial omissions that inflated stock prices improperly. The law firm’s services are provided without the need for upfront costs to the shareholders, making the process accessible for those looking to pursue their rights.

Next Steps

For shareholders interested in exploring their options, the registration process is straightforward. Ensure that you gather any pertinent documents related to your Cerevel stock purchases. When you register through The Gross Law Firm, you will be placed into a portfolio monitoring system where you can track ongoing status updates regarding your claims.

In a world where transparency and honesty should prevail in business practices, affected shareholders deserve an opportunity to recover what is rightfully theirs. Do not hesitate to seek out The Gross Law Firm’s expertise if you believe your rights as an investor have been compromised.

Contact Information:
The Gross Law Firm
15 West 38th Street, 12th floor
New York, NY, 10018
Phone: (646) 453-8903
Email: contact@thegrosslawfirm.com